Search

everythinglearnresearchcommunity

for

Search:↓

Apigenin may effectively promote hair growth for androgenetic alopecia when applied topically.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

In Spain, dermatologists most commonly prescribe topical minoxidil and oral finasteride for male hair loss, and topical minoxidil and oral contraceptives for female hair loss. The use of oral dutasteride and oral minoxidil has significantly increased over the past three years.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Chitosan-coated nanoparticles improve skin delivery of hair loss treatments with fewer side effects.

Finasteride 5 mg and topical minoxidil 5% effectively increase hair density in women, with finasteride 5 mg having the highest satisfaction.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Use minoxidil for hair loss treatment; assess results after 6 months.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Hair restoration can be achieved through non-surgical treatments like minoxidil, antiandrogens, phototherapy, and PRP procedures, or through surgical methods like hair transplantation. Continued treatment is needed to maintain results, and full results are visible after 12-18 months.

Topical minoxidil helps treat hair loss in teens, but more research needed for safe options.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Best hair growth results from combining finasteride and minoxidil.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Use minoxidil for hair loss treatment, and finasteride for men.

Treat pattern hair loss with finasteride and topical minoxidil.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Scalp massages may help stabilize or regrow hair in people suffering from hair loss, regardless of age, gender, or use of other treatments.